首页 | 本学科首页   官方微博 | 高级检索  
     

脂质体载药系统与抗肿瘤药物
引用本文:宫亮,杨和平. 脂质体载药系统与抗肿瘤药物[J]. 中国药业, 2005, 14(3): 27-29
作者姓名:宫亮  杨和平
作者单位:第三军医大学西南医院呼吸科,重庆,400038
摘    要:目的:介绍脂质体载药系统在抗肿瘤药物治疗中的应用.方法:采用文献综述方法,主要介绍普通脂质体和一些经过修饰后的脂质体作为药物载体的研究情况.结果:脂质体作为抗肿瘤药物的载体是可行的,可显著降低抗肿瘤药物的毒副作用,增加血药浓度并延长作用时间,还可明显提高抗肿瘤药物作用的靶向性.结论:脂质体是抗肿瘤药物的理想载体,在抗肿瘤治疗中有广泛的应用前景.

关 键 词:脂质体  药物载体  抗肿瘤治疗
文章编号:1006-4931(2005)03-0027-02
修稿时间:2004-08-18

Liposome and Antitumor Drug Therapy
GONG Liang,Yang Heping. Liposome and Antitumor Drug Therapy[J]. China Pharmaceuticals, 2005, 14(3): 27-29
Authors:GONG Liang  Yang Heping
Abstract:Objective:To review the research progress of liposome on antitumor therapy as a novel class of drug carriers.Methods:Researches of common liposomes and modified liposomes were reviewed in recent years at home and abroad.Results:It is feasible to select liposome as the drug carrier of antitumor drugs.It can greatly decrease the toxicity,increasing blood concentration after administration,and also develop the targeting effect of the encapsulated drugs.Conclusion:Liposome is an ideal carrier of antitumor drugs.It has extensive prospect in antitumor therapy.
Keywords:liposome  drug carrier  antitumor therapy
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号